Goodwin assisted Metagenomi on the matter. Preclinical biotech Metagenomi went public on the Nasdaq under the ticker “MGX”, raising $94 million by offering 6.25 million shares...
You must be a Standard 1 Year member to access this content.
Troutman Pepper advised TELA Bio on the deal. TELA Bio announced the closing of its previously announced underwritten public offering of 4,600,000 shares of its common...
You must be a Standard 1 Year member to access this content.
Troutman Pepper advised Century Therapeutics on the deal. Century Therapeutics (NASDAQ: IPSC) has announced a research collaboration and license agreement with Bristol Myers Squibb (NYSE: BMY)...
You must be a Standard 1 Year member to access this content.
